Vtv Therapeutics Stock Price Prediction
| VTVT Stock | USD 24.44 0.40 1.66% |
Oversold Vs Overbought
64
Oversold | Overbought |
vTv Therapeutics stock price prediction is an act of determining the future value of VTv Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of VTv Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of VTv Therapeutics and does not consider all of the tangible or intangible factors available from VTv Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with vTv Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting VTv Therapeutics' stock price prediction:Wall Street Target Price 2 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of VTv Therapeutics based on different types of headlines from major news networks to social media. The VTv stock price prediction module provides an analysis of price elasticity to changes in media outlook on VTv Therapeutics over a specific investment horizon. Using VTv Therapeutics hype-based prediction, you can estimate the value of vTv Therapeutics from the perspective of VTv Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in VTv Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in VTv Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying VTv because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
VTv Therapeutics after-hype prediction price | USD 25.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
VTv |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VTv Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
VTv Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of VTv Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in VTv Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of VTv Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
VTv Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting VTv Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on VTv Therapeutics' historical news coverage. VTv Therapeutics' after-hype downside and upside margins for the prediction period are 11.58 and 39.38, respectively. We have considered VTv Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
VTv Therapeutics is unstable at this time. Analysis and calculation of next after-hype price of vTv Therapeutics is based on 3 months time horizon.
VTv Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as VTv Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VTv Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with VTv Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.36 | 13.90 | 1.04 | 0.68 | 10 Events / Month | 16 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
24.44 | 25.48 | 4.26 |
|
VTv Therapeutics Hype Timeline
vTv Therapeutics is at this time traded for 24.44. The entity has historical hype elasticity of 1.04, and average elasticity to hype of competition of 0.68. VTv is anticipated to increase in value after the next headline, with the price projected to jump to 25.48 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 4.26%, whereas the daily expected return is at this time at 2.36%. The volatility of related hype on VTv Therapeutics is about 4853.97%, with the expected price after the next announcement by competition of 25.12. vTv Therapeutics currently holds about 17.95 M in cash with (18.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out VTv Therapeutics Basic Forecasting Models to cross-verify your projections.VTv Therapeutics Related Hype Analysis
Having access to credible news sources related to VTv Therapeutics' direct competition is more important than ever and may enhance your ability to predict VTv Therapeutics' future price movements. Getting to know how VTv Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how VTv Therapeutics may potentially react to the hype associated with one of its peers.
VTv Therapeutics Additional Predictive Modules
Most predictive techniques to examine VTv price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VTv using various technical indicators. When you analyze VTv charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About VTv Therapeutics Predictive Indicators
The successful prediction of VTv Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as vTv Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of VTv Therapeutics based on analysis of VTv Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to VTv Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to VTv Therapeutics's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0173 | 0.0154 | Price To Sales Ratio | 28.29 | 26.88 |
Story Coverage note for VTv Therapeutics
The number of cover stories for VTv Therapeutics depends on current market conditions and VTv Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that VTv Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about VTv Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
VTv Therapeutics Short Properties
VTv Therapeutics' future price predictability will typically decrease when VTv Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of vTv Therapeutics often depends not only on the future outlook of the potential VTv Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. VTv Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.1 M | |
| Cash And Short Term Investments | 9.4 M |
Check out VTv Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for VTv Stock analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.71) | Revenue Per Share 0.004 | Return On Assets (0.72) | Return On Equity (49.78) |
The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.